5 Easy Facts About is nembutal a depressant Described
5 Easy Facts About is nembutal a depressant Described
Blog Article
pentobarbital will lower the extent or influence of cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the level or effect of lapatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will lower the extent or impact of ramelteon by affecting hepatic enzyme CYP2C9/10 metabolism. Small/Significance Mysterious.
pentobarbital will decrease the level or outcome of aripiprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will decrease the extent or effect of paclitaxel protein sure by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Mysterious.
pentobarbital will lower the level or effect of diazepam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
fentanyl transdermal and pentobarbital both enhance sedation. Prevent or Use Alternate Drug. Restrict use to clients for whom choice treatment choices are insufficient
CYP3A4 inducers may enhance the metabolism of clopidogrel to its Energetic metabolite. Keep track of people for probable increase in antiplatelet effects when CYP3A4 inducers are used together with clopidogrel
pentobarbital will reduce the level or result of vardenafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will lower the extent or influence of armodafinil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. click here Insignificant/Importance Not known.
pentobarbital and daridorexant both boost sedation. Modify Therapy/Watch Closely. Coadministration will increase hazard of CNS depression, which may result in additive impairment of psychomotor overall performance and lead to daytime impairment.
pentobarbital will reduce the extent or outcome of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Avoid coadministration of bedaquiline with robust CYP3A4 inducers resulting from potential for lowered therapeutic influence
pentobarbital will decrease the level or influence of fosphenytoin by affecting hepatic enzyme CYP2C9/10 metabolism. Use Warning/Monitor.
pentobarbital will reduce the level or influence of fentanyl transmucosal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Coadministration of fentanyl with CYP3A4 inducers may lead to the decrease in fentanyl plasma concentrations, insufficient efficacy or, potentially, enhancement of the withdrawal syndrome inside a individual who's got made physical dependence to fentanyl.